FDAnews
www.fdanews.com/articles/102604-data-about-zetia-risks-were-not-fully-revealed

Data About Zetia Risks Were Not Fully Revealed

December 26, 2007
New evidence shows that the drug makers Merck and Schering-Plough have conducted several studies of their popular cholesterol medicine Zetia that raise questions about its risks to the liver, but the companies have never published those results.
The New York Times